Long-term survival following acute MI in Australia is now among the world’s best, although there’s room for improvement for older patients and those with non-ST elevation MI, a study shows.

A seven-year survival rate of more than 85% among adults younger than 65 is attributable to significant advances in treatments offered both in and out of hospital, the researchers say.